Fluglucoscan 0.5 Gbq

Fludeoxyglucose 18F is a radiopharmaceutical solution used in diagnostic imaging. This intravenous solution is designed for medical imaging procedures to help visualize metabolic activity.

Fludeoxyglucose 18F is primarily used in positron emission tomography (PET) scans. This radiopharmaceutical helps in the detection and evaluation of metabolic activity in various tissues. It is often utilized in the assessment of conditions that affect metabolic processes, such as certain types of cancer and neurological disorders.

Fludeoxyglucose 18F works by being absorbed by cells with high metabolic rates. This absorption can be visualized through PET imaging, providing detailed images of metabolic activity. The effects are typically temporary and localized to the areas being imaged.

Fludeoxyglucose 18F should be handled with care due to its radioactive nature. It is important to follow proper safety protocols to minimize exposure. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Fludeoxyglucose 18F may interact with other medications or substances that affect metabolic processes. It is important to discuss all current medications with a healthcare provider before undergoing a PET scan. Alcohol and certain foods may also affect the accuracy of the imaging results.